Enhabit, Inc. (EHAB) is a publicly traded Healthcare sector company. As of May 21, 2026, EHAB trades at $13.80 with a market cap of $706.91M and a P/E ratio of -153.33. EHAB moved +0.11% today. Year to date, EHAB is +46.50%; over the trailing twelve months it is +30.43%. Its 52-week range spans $6.47 to $14.22. Analyst consensus is neutral with an average price target of $13.80. Rallies surfaces EHAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes EHAB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $13.80 |
| Market Cap | $706.91M |
| P/E Ratio | -153.33 |
| EPS | $-0.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.22 |
| 52-Week Low | $6.47 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.06B |
| Net Income | $-2.60M |
| Gross Margin | 0.00% |
6 analysts cover EHAB: 0 strong buy, 0 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $13.80.